Award notice Supplies
VACCINS 2024-2028
Notice published in French. The AI analysis summarises it for you in your language.
- Public buyer
- HUmani SC
Charleroi - Place of performance
- 6110 Montigny-le-Tilleul, Hainaut
- Amount awarded
- €439,276 excl. VAT
- Planned end of contract
- 1 December 2028
likely re-tender around June 2028 - Bids received
- 1
- Form
- Framework agreement
Multi-year contract: the buyer places orders as needs arise. - Procedure
- Open procedure
Any company may submit a bid. - Publication
- 19 November 2024
- Notice language
- French
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Le présent marché a pour objet la fourniture de vaccins. Ces produits seront commandés pour HUmani s.c. - CHU de Charleroi - Chimay, agissant en centrale d’achat.
Awarded to
7 lots
- Vaccins contre l'hépatite A
- Vaccin contre l'hépatite B
- Vaccin contre la rougeole, rubéole et oreillons
- Vaccin contre la diphtérie, tétanos et coqueluche
- Vaccins contre la méningite
- Vaccin contre la diphtérie, le tétanos, la coqueluche et la poliomyélite
- Vaccin hexavalent
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33651600
Winning prices for comparable contracts
- A quarter below
- €290,000
- Median
- €403,000
- A quarter above
- €1,351,075
Amounts awarded (excl. VAT) over the last 3 years for 5 contracts in the same CPV group (3365…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| Immunoglobuline humaine normale pour administration intraveineuse Cliniques universitaires Saint Luc · 22 October 2026 |
CSL BEHRING | €16,277,080 |
| Antimycotica AZ Delta vzw · 21 October 2026 |
Arega Pharma NV Sandoz NV Fresenius Kabi NV Pfizer NV |
€300,945 |
| Purchase, storage and delivery of live attenuated homologous vaccine against Lumpy Skin Disease European Commission, DG SANTE - Health and Food Safety · 1 October 2026 |
Huvepharma EOOD | €2,385,950 |
| Raamovereenkomst voor het leveren van immunoglobulines IV 10% Universitair Ziekenhuis Gent · 24 September 2026 |
CSL BEHRING NV | €27,360,000 |
| Aankoop en levering van plasmaderivaten Algemeen Ziekenhuis Sint-Maria vzw · 15 September 2026 |
CSL BEHRING DEPARTEMENT CENTRAL DE FRACTIONNEMENT Prothya Biosolutions Netherlands B.V. OCTAPHARMA BENELUX |
€18,749,295 |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 704707-2024.